Pharmacogenetics, pharmacogenomics and airway disease

Hall, Ian P. (2002) Pharmacogenetics, pharmacogenomics and airway disease. Respiratory Research, 3 (1). p. 10.

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
68Kb

Abstract

The availability of a draft sequence for the human genome will revolutionise research into airway disease. This review deals with two of the most important areas impinging on the treatment of patients: pharmacogenetics and pharmacogenomics. Considerable inter-individual variation exists at the DNA level in targets for medication, and variability in response to treatment may, in part, be determined by this genetic variation. Increased knowledge about the human genome might also permit the identification of novel therapeutic targets by expression profiling at the RNA (genomics) or protein (proteomics) level. This review describes recent advances in pharmacogenetics and pharmacogenomics with regard to airway disease

Item Type:Article
Schools/Departments:University of Nottingham UK Campus > Faculty of Medicine and Health Sciences > School of Medicine
ID Code:123
Deposited By:Gardner, Mike
Deposited On:04 May 2004
Last Modified:08 May 2014 17:05

Repository Staff Only: item control page